EQR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Equity Residential (EQR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has shown slight positive momentum in the short term, its financial performance is weakening, insider selling is significant, and technical indicators do not suggest a strong entry point. Analysts' ratings are mixed, with some downgrades and price target reductions. The options data also indicates a bearish sentiment with a high Open Interest Put-Call Ratio. Given these factors, holding off on investing in EQR until stronger positive catalysts emerge would be prudent.
The MACD histogram is negative and contracting, indicating weak momentum. RSI is neutral at 61.466, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 64.685), suggesting limited upside potential in the short term.
The Bozzuto Group's partnership with Invesco to invest $1 billion in older multifamily assets on the East Coast could indirectly benefit Equity Residential by enhancing competitiveness in the multifamily market.
Insider selling has increased significantly (1039.38% over the last month), indicating potential lack of confidence from insiders. Financial performance shows declining net income (-8.84% YoY) and EPS (-9.09% YoY), along with a slight drop in gross margin (-0.83% YoY). Analysts have downgraded the stock, citing softening fundamentals in key markets.
In Q4 2025, revenue increased by 1.97% YoY to $781.91 million. However, net income dropped by 8.84% YoY to $381.74 million, and EPS fell by 9.09% YoY to $1. Gross margin slightly declined to 63.29%, down 0.83% YoY.
Analysts' ratings are mixed. Recent upgrades include UBS raising the price target to $71, citing a potential REIT turnaround in 2026. However, Deutsche Bank and BMO Capital downgraded the stock, citing softening fundamentals and affordability concerns. The current price is near Cantor Fitzgerald's raised target of $64, suggesting limited upside.
